Radiotherapy for bladder cancer.

[1]  P. Dombernowsky,et al.  Histology and cell proliferation in human bladder tumors. An autoradiographic study , 1974, Cancer.

[2]  P. Warde,et al.  Bladder cancer: long-term follow-up results of patients treated with radical radiation. , 1991, Clinical oncology (Royal College of Radiologists (Great Britain)).

[3]  W. Shipley,et al.  Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  R. Buller,et al.  Use of ileocecal continent urinary reservoir in patients with previous pelvic irradiation. , 1992, Gynecologic oncology.

[5]  A. Hart,et al.  Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control. , 1998, International journal of radiation oncology, biology, physics.

[6]  Palou,et al.  Intravesical bacille Calmette‐Guérin in the treatment of carcinoma in situ or high‐grade superficial bladder carcinoma after radiotherapy for bladder carcinoma , 1999, BJU international.

[7]  L. Akslen,et al.  Radical radiation treatment of invasive and locally advanced bladder carcinoma in elderly patients. , 1991, British journal of urology.

[8]  C. Fowler,et al.  Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer. , 1988, British journal of urology.

[9]  A. Gerbaulet,et al.  Interstitial iridium-192 for bladder cancer (a multicentric survey: 205 patients). , 1992, International Journal of Radiation Oncology, Biology, Physics.

[10]  W. Hop,et al.  Carcinoma of the urinary bladder (category T1NxM0) treated either by radium implant or by transurethral resection only. , 1981, International journal of radiation oncology, biology, physics.

[11]  W. De Neve,et al.  T1 and T2 carcinoma of the urinary bladder: long term results with external, preoperative, or interstitial radiotherapy. , 1992, International journal of radiation oncology, biology, physics.

[12]  J. Paradelo,et al.  Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study. , 1997, The Journal of urology.

[13]  J. Dunn,et al.  Neo-adjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder. , 1991, British journal of urology.

[14]  H. Müller-Gärtner,et al.  Staging of Pelvic Lymph Nodes in Neoplasms of the Bladder and Prostate by Positron Emission Tomography with 2-[18F]-2-Deoxy-D-Glucose , 1999, European Urology.

[15]  P. Abrams,et al.  Evidence--based medicine overview of the main steps for developing and grading guideline recommendations. , 2007, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[16]  D. Pfleger,et al.  Small pelvic lymph node metastases: evaluation with MR imaging. , 1997, Clinical radiology.

[17]  H. Bloom,et al.  Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. , 1982, British journal of urology.

[18]  W. Duncan,et al.  The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  S. Davidson,et al.  Assessment of factors influencing the outcome of radiotherapy for bladder cancer. , 1990, British journal of urology.

[20]  D. Hedley,et al.  Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  W. Hop,et al.  Cancer of the urinary bladder category T2, T3, (NxMo) treated by interstitial radium implant: second report. , 1983, International journal of radiation oncology, biology, physics.

[22]  S. Groshen,et al.  The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. , 1993, The Journal of urology.

[23]  C. Vale.  Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis , 2003, The Lancet.

[24]  J. Herman,et al.  Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis. , 1989, The Journal of urology.

[25]  H. Barlebo,et al.  Treatment of advanced bladder cancer category T2 T3 and T4a. A randomized multicenter study of preoperative irradiation and cystectomy versus radical irradiation and early salvage cystectomy for residual tumor. DAVECA protocol 8201. Danish Vesical Cancer Group. , 1991, Scandinavian journal of urology and nephrology. Supplementum.

[26]  P. R. Timmer,et al.  Bladder cancer: pattern of recurrence in 142 patients. , 1985, International journal of radiation oncology, biology, physics.

[27]  M. Palmer,et al.  Factors influencing salvage cystectomy results. , 1982, British journal of urology.

[28]  W. Shipley,et al.  Invasive bladder carcinoma. The importance of initial transurethral surgery and other significant prognostic factors for improved survival with full‐dose irradiation , 1987, Cancer.

[29]  C. Rödel,et al.  Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation. , 2000, International journal of radiation oncology, biology, physics.

[30]  I. Tannock,et al.  Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  B. Czerniak,et al.  Retinoblastoma protein expression and radiation response in muscle-invasive bladder cancer. , 1997, International journal of radiation oncology, biology, physics.

[32]  M. Droller.  Neoadjuvant cisplatin,methotrexate,and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial , 1999, The Lancet.

[33]  P. Albers,et al.  Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  D. Skinner,et al.  High dose, short course preoperative radiation therapy and immediate single stage radical cystectomy with pelvic node dissection in the management of bladder cancer. , 1982, The Journal of urology.

[35]  K. Ang,et al.  Clinical Target Volumes in Conformal and Intensity Modulated Radiation Therapy , 2003, Medical Radiology.

[36]  K. Trott,et al.  What is known about tumour proliferation rates to choose between accelerated fractionation or hyperfractionation? , 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[37]  W. Mackillop,et al.  A population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer. , 1999, International journal of radiation oncology, biology, physics.

[38]  M. Dewhirst,et al.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. , 1996, Cancer research.

[39]  G. Kerr,et al.  Radical radiotherapy and salvage cystectomy as the primary management of transitional cell carcinoma of the bladder. Results following the introduction of a CT planning technique. , 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

[40]  O. S. Nielsen,et al.  Neoadjuvant Chemotherapy with Cisplatin and Methotrexate in Patients with Muscle-Invasive Bladder Tumours , 2002, Acta oncologica.

[41]  W. Duncan,et al.  Treatment of superficial (T1) tumours of the bladder by radical radiotherapy. , 1986, British journal of urology.

[42]  A. Pollack,et al.  Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors. , 1994, International journal of radiation oncology, biology, physics.

[43]  R. Fisher,et al.  Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder. , 1995, International journal of radiation oncology, biology, physics.

[44]  Z. Petrovich,et al.  Salvage radical cystoprostatectomy and orthotopic urinary diversion following radiation failure. , 1998, The Journal of urology.

[45]  E. Crawford,et al.  Salvage cystectomy after irradiation failure. , 1980, The Journal of urology.

[46]  S. Johansson,et al.  A prospective randomized study of preoperative irradiation with cystectomy or cystectomy alone for invasive bladder carcinoma. , 1983, European urology.

[47]  M. Stöckle,et al.  Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience. , 1995, The Journal of urology.

[48]  R. Dodge,et al.  The value of pathologic factors in predicting cancer‐specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate , 1993, Cancer.

[49]  Richard P. Hill,et al.  The hypoxic tumour microenvironment and metastatic progression , 2004, Clinical & Experimental Metastasis.

[50]  H. Wolf,et al.  UROTHELIAL DYSPLASIA CONCOMITANT WITH BLADDER TUMOURS: A DETERMINANT FOR FUTURE NEW OCCURRENCES IN PATIENTS TREATED BY FULL-COURSE RADIOTHERAPY , 1985, The Lancet.

[51]  J. Parsons,et al.  Bladder-sparing approach in the treatment of invasive bladder cancer. , 1990, Seminars in urology.

[52]  A. Zietman,et al.  Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder. , 2001, Urology.

[53]  R. Weichselbaum,et al.  Curative radiotherapy following chemotherapy for invasive bladder carcinoma (a preliminary report). , 1991, International journal of radiation oncology, biology, physics.

[54]  P. Koper,et al.  Muscle invasive bladder cancer treated by transurethral resection, followed by external beam radiation and interstitial iridium-192. , 1997, International journal of radiation oncology, biology, physics.

[55]  S. Fosså,et al.  Bladder cancer definitive radiation therapy of muscle‐invasive bladder cancer: A retrospective analysis of 317 patients , 1993, Cancer.

[56]  T. Ekfors,et al.  Single-stage salvage cystectomy: results and complications in 20 patients. , 1989, European urology.

[57]  A. Zietman,et al.  Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. , 2002, Urology.

[58]  W. Duncan,et al.  The influence of hemoglobin level on the regression and long term local control of transitional cell carcinoma of the bladder following photon irradiation. , 1986, International journal of radiation oncology, biology, physics.

[59]  James B. Mitchell,et al.  Tumor hypoxia: chicken, egg, or a piece of the farm? , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  H. Bloom,et al.  Adjuvant chemotherapy in T3 carcinoma of the bladder. A prospective trial: preliminary report. , 1988, British journal of urology.

[61]  H. Bartelink,et al.  Bladder conservation in selected T1G3 and muscle-invasive T2-T3a bladder carcinoma using combination therapy of surgery and iridium-192 implantation. , 1994, British journal of urology.

[62]  M. Coptcoat,et al.  Measurement of in vivo urological tumour cell kinetics using multiparameter flow cytometry. Preliminary study. , 1991, British journal of urology.

[63]  W. Whitmore,et al.  Salvage cystectomy for bladder cancer after failure of definitive irradiation. , 1981, The Journal of urology.

[64]  B. Donnelly,et al.  Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of radiation therapy oncology group 89-03. , 1998, The Journal of urology.

[65]  S. Jahnson,et al.  Bladder carcinoma--a 20-year review of radical irradiation therapy. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[66]  C. Fowler,et al.  Radical radiotherapy and salvage cystectomy for T2/3 cancer of the bladder. , 1988, Progress in clinical and biological research.

[67]  H. Bartelink,et al.  Fractionation in radiotherapy. , 1994, Cancer treatment reviews.

[68]  A. Young.  Acute jejunitis; report of a case. , 1949, Lancet.

[69]  J. Muscat,et al.  Planned preoperative radiation therapy in muscle invasive bladder cancer; results of a meta-analysis. , 1998, Anticancer research.

[70]  A. Hart,et al.  Muscle-invasive bladder cancer treated with external beam radiotherapy: pretreatment prognostic factors and the predictive value of cystoscopic re-evaluation during treatment. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[71]  R. Oliver,et al.  T3 bladder cancer--the case for salvage cystectomy. , 1980, British journal of urology.

[72]  J. Dunst,et al.  Radiotherapy is an Effective Treatment for High-Risk T1-Bladder Cancer , 2001, Strahlentherapie und Onkologie.

[73]  D. Goffinet,et al.  Bladder cancer: results of radiation therapy in 384 patients. , 1975, Radiology.

[74]  A. V. von Eschenbach,et al.  Salvage cystectomy for bladder carcinoma , 1981, Cancer.

[75]  C. Dinney,et al.  Preoperative radiotherapy for muscle‐invasive bladder carcinoma. Long term follow‐up and prognostic factors for 338 patients , 1994, Cancer.

[76]  H. Grossman,et al.  Salvage cystectomy following failed definitive radiation therapy for transitional cell carcinoma of bladder. , 1985, Urology.

[77]  W. Whitmore,et al.  Randomized trial of cystectomy with or without preoperative radiotherapy for carcinoma of the bilharzial bladder. , 1985, The Journal of urology.

[78]  F. Freiha,et al.  A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. , 1996, The Journal of urology.

[79]  W. Shipley,et al.  Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival. , 1985, The Journal of urology.

[80]  P. Hoskin,et al.  GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON , 2003, British Journal of Cancer.

[81]  T. Wilt,et al.  A meta-analysis of randomised trials suggests a survival benefit for combined radiotherapy and radical cystectomy compared with radical radiotherapy for invasive bladder cancer: are these data relevant to modern practice? , 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

[82]  A. Murtha,et al.  Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors. , 2001, International journal of radiation oncology, biology, physics.

[83]  L. Mazzucchelli,et al.  Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial. , 1994, The Journal of urology.

[84]  L. Solin,et al.  Prognostic factors in patients with bladder carcinoma treated with definitive irradiation , 1990, Cancer.

[85]  L. True,et al.  Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[86]  J. Elwood,et al.  Conservation of bladder function in patients with invasive bladder cancer treated by definitive irradiation and selective cystectomy. , 1981, International journal of radiation oncology, biology, physics.

[87]  R. A’Hern,et al.  Predicting the outcome of radical radiotherapy for invasive bladder cancer. , 1993, European urology.

[88]  P. Bassi,et al.  Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. , 1999, The Journal of urology.

[89]  B. Czerniak,et al.  Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[90]  G. Griffiths.  Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists , 1999 .

[91]  W. H. Kern,et al.  The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. , 1991, The Journal of urology.

[92]  D. Tolley,et al.  Results of surgery following radical radiotherapy for invasive bladder cancer. , 1986, British journal of urology.

[93]  G. A. King,et al.  Bladder carcinoma: Experiences with radical and preoperative radiotherapy in 421 patients , 1984 .

[94]  J. Dunst,et al.  Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[95]  J. Witjes,et al.  What is new in bladder cancer imaging. , 1997, The Urologic clinics of North America.

[96]  A. Agranovich,et al.  Radiotherapy for muscle-invasive urinary bladder cancer in elderly patients. , 2002, The Canadian journal of urology.

[97]  B. Czerniak,et al.  Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer. , 1996, International journal of radiation oncology, biology, physics.

[98]  L. Pisters,et al.  Intravesical bacillus Calmette-Guerin or mitomycin C in the treatment of carcinoma in situ of the bladder following prior pelvic radiation therapy. , 1991, The Journal of urology.

[99]  A. Zietman,et al.  Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors. , 2003, The Journal of urology.

[100]  L. Miller.  Bladder cancer. Superiority of preoperative irradiation and cystectomy in clinical stages B2 and C , 1977, Cancer.

[101]  A. Hart,et al.  Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder. , 2001, International journal of radiation oncology, biology, physics.

[102]  C. Dinney,et al.  Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone. , 1995, International journal of radiation oncology, biology, physics.

[103]  L. Freedman,et al.  Adjuvant chemotherapy with doxorubicin (Adriamycin) and 5-fluorouracil in T3, NX, MO bladder cancer treated with radiotherapy. , 1983, British journal of urology.